Clinical trial

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

NCT01620593

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-04-01

PhasePHASE2

Study timeline

Study start (unknown)2011-04-01Date precision: month

Registry last updated2018-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PlaceboDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01620593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.